EGFR exon 20 insertion mutations – identifying and managing patients in the UK
Originally live on Thursday 2nd March, 2023, 6:00pm – 7:00pm GMT
In the first roundtable in a series of Lung Cancer Sessions organized by VJOncology and BTOG, leading UK thoracic experts Sanjay Popat, Alastair Greystoke, Anna Minchom and Riyaz Shah will discuss the identification of EGFR exon 20 insertion mutations and how to manage patients in the UK, based on the recent decisions made by NICE on the use of amivantamab and mobocertinib.